Preferred Label : ACE Inhibitor;
NCIt related terms : angiotensin-converting enzyme inhibitor; ACE-inhibitor; Angiotensin-converting enzyme (ACE) inhibitor medication;
NCIt definition : Any substance that inhibits angiotensin-converting enzyme (ACE), an enzyme that catalyzes
the conversion of angiotensin I to angiotensin II. Inhibition of ACE results in a
reduction in angiotensin II and angiotensin II-induced aldosterone secretion, causing
vasodilation and natriuresis.;
Alternative definition : NICHD: A pharmaceutical agent that inhibits angiotensin-converting enzyme (ACE), which
catalyzes the conversion of angiotensin I to angiotensin II. Inhibition of ACE results
in a reduction in angiotensin II and angiotensin II-induced aldosterone secretion,
causing vasodilation and natriuresis. It is primarily used for the reduction of proteinuria
and the treatment of hypertension.; NCI-GLOSS: A drug that is used to lower blood pressure. An ACE inhibitor is a type
of antihypertensive agent.; ACC/AHA: A medication that inhibits ACE, an enzyme that catalyzes the conversion of
angiotensin I to angiotensin II. Inhibition of ACE results in a reduction in angiotensin
II and angiotensin II-induced aldosterone secretion, causing vasodilation and natriuresis.;
ChEBI ID : CHEBI:35457;
Codes from synonyms : CDR0000335481; CDR0000335479;
Origin ID : C247;
UMLS CUI : C0003015;
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
Currated CISMeF NLP mapping
False automatic mappings
Semantic type(s)
UMLS correspondences (same concept)
concept_is_in_subset
https://www.cochrane.org/fr/CD006257/RENAL_inhibiteurs-de-lenzyme-de-conversion-de-langiotensine-et-antagonistes-des-recepteurs-de
2024
United Kingdom
review of literature
french abstract
Progression
Upon Progression
diabetic nephropathies
angiotensin receptor site
Diabetic Nephropathy
angiotensin-converting enzyme inhibitor agent, nos
Receptor
Preventive Intervention
ACE Inhibitor
Prevention
angiotensin-converting enzyme inhibitors
angiotensin receptor antagonists
Prevention Study
Cancer Progression
---
https://n2t.net/ark:/47881/m64x57rx
2023
France
dissertations, academic
arteriopathy
Meta-Analysis
randomized controlled trials as topic
Efficacy Study
occlusion of artery, nos
Arterial Disorder
efficiency
meta-analysis as topic
all extremities
arterial occlusive diseases
extremities
angiotensin-converting enzyme inhibitors
angiotensin-converting enzyme inhibitor agent, nos
Murine Limb
Review
Meta-Analysis
classification
Systematic Review
ACE Inhibitor
Extremity Part
Membership
---